Observational Study Evaluating the LDL-C [low density lipoprotein cholesterol] Lowering Effects of Ezetimibe With a Statin [HMG-CoA reductase inhibitor] as Prescribed in Daily Routine Practice in an Indonesian Population.

Trial Profile

Observational Study Evaluating the LDL-C [low density lipoprotein cholesterol] Lowering Effects of Ezetimibe With a Statin [HMG-CoA reductase inhibitor] as Prescribed in Daily Routine Practice in an Indonesian Population.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jul 2014

At a glance

  • Drugs Ezetimibe (Primary) ; HMG-CoA reductase inhibitors
  • Indications Hypercholesterolaemia
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Merck Sharp & Dohme; Schering-Plough
  • Most Recent Events

    • 05 Aug 2009 Actual patient number (453) added as reported by ClinicalTrials.gov.
    • 21 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top